Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins

Published:2011-04-07 Issue:16 Volume:71 Page:1810-1817
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Sánchez Catherine,Mercado Alejandro,Contreras Héctor R.,Mendoza Patricia,Cabezas Juan,Acevedo Cristian,Huidobro Christian,Castellón Enrique A.

Funder

Fondo Nacional de Ciencia y Tecnología (FONDECYT) Project

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.21398/fullpdf

Reference29 articles.

1. Estimates of cancer incidence and mortality in Europe in 2008;Ferlay;Eur J Cancer,2010

2. Targeted therapy for advanced prostate cancer: Looking through new lenses;Vogiatzi;Drug News Perspect,2009

3. The treatment of hormone-refractory prostate cancer: Docetaxel and beyond;Petrylak;Rev Urol,2006

4. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frizzled-3 suppression overcomes multidrug chemoresistance by Wnt/β-catenin signaling pathway inhibition in hepatocellular carcinoma cells;Journal of Chemotherapy;2023-02-27

2. Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer;Pathology - Research and Practice;2023-01

3. Cancer Stemness/Epithelial–Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target;International Journal of Molecular Sciences;2022-11-29

4. siRNA-Based Carrier-Free System for Synergistic Chemo/Chemodynamic/RNAi Therapy of Drug-Resistant Tumors;ACS Applied Materials & Interfaces;2021-12-21

5. The miRNAs involved in prostate cancer chemotherapy response as chemoresistance and chemosensitivity predictors;Andrology;2021-08-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3